Specifically, these trials are intended to:
-Investigate the biology of relapse;
-Validate new proposed molecular definitions of relapse;
-Assess interventions designed to prevent relapse; and
-Evaluate approaches to treat relapse.

Additional Aims of the Workshop are to:
-Update the current state of the science relative to the biology and clinical studies of relapse after allogeneic HSCT;
-Present an overview on the biology and clinical studies of relapse after autologous stem cell transplantation;
-Provide a forum to present laboratory and clinical research, including ongoing clinical trials, specific to the study and treatment of relapse following HSCT.